Clopidogrel and Clopidogrel + Asprin with the brand name of PlatridTM 75mg Tablets and PlatridTM-AP 75/75mg Tablets has been introduced in pack of 10s
Sitagliptin Phosphate + Metformin HCI with the brand name of ITAGLIP® Plus 50mg/850mg Tablets has been introduced in pack of 14’s
Sacubitril/Valsartan with the brand name of VALSATRILTM 24mg/26mg Tablets & 49mg/51mg Tablets has been introduced in pack of 14’s
Midazolam with the brand name of IDZO® 5mg/5ml inj. Has been introduced in pack of 30ml
Tapentadol with the brand name of TapentoTM IR 75mg Tablets has been introduced in pack of 10’s
Tramadol + Paracetamol with the brand name of Tonoflex-P Forte Tablets has been introduced in pack of 10’s
SAMI pharmacovigilance program, is your partner for safer use of medicines.
At SAMI, We are steadfast to improve patient care and safety by embracing Good Pharmacovigilance Practices. We at SAMI Pharmaceuticals (Pvt.) Ltd., strongly believe that timely reporting of all safety information linked to our medicinal products plays a vital role in safer use of our medicines. Program of SAMI will assist, via continuous monitoring of drug’s safety, in building trust on overall safety & efficacy of our products and ultimately encourage safer medicinal use of our quality products, benefiting Public Health
Be our partner by playing your role in this critical process!
Your valuable inputs would enable us to ensure our patients wellbeing
We firmly believe,
“Reporting Makes Medicines Safer!”
Please learn more using Drug Safety at SAMI for making effective reporting of adverse event/s. To report suspected adverse event/s related to any SAMI’s product, you can Contact Us on below details provided for reporting of suspected adverse event/s.